Drug-Eluting Stent in BTK-arteries – 12 month results of the PREVENT study

12-month results of the PREVENT study, investigating the Promus Element Plus stent system from Boston Scientific in Below-The-Knee arteries.

70 Critical Limb Ischemia patients were enrolled in 5 different sites, divided over Belgium and Germany.

With 12-month Primary Patency rates of 86.2% & freedom of TLR-rates of 93.0%, there is definitely some evidence for Drug-Eluting-Stents in the CLI-BTK area.


Leave a Reply